Incyte Corp Reports Strong Q1 Performance, Raises Revenue Guidance for Jakafi
Incyte Corp reports strong Q1 2025 performance, exceeding revenue estimates and raising revenue guidance for its flagship product Jakafi to $3 billion.
2 minutes to read
Incyte Corp to Showcase Oncology Data at AACR and ASCO 2025 Conferences
Incyte Corporation will present new oncology data at the AACR and ASCO Annual Meetings in 2025, highlighting its commitment to advancing cancer treatment and research.
2 minutes to read